Tarsus Pharmaceuticals
TARS
$38.24
Share price
-0.88%
Change (1 day)
140.05%
Change (1 year)
Categories
Tarsus Pharmaceuticals (TARS) - P/B ratio
P/B ratio as of May 2024 : 7.40
According to Tarsus Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 7.40.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Tarsus Pharmaceuticals - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.40 | 67.89% |
| 2022-12-31 | 2.03 | -27.36% |
| 2021-12-31 | 2.79 | -44.85% |
| 2020-12-31 | 5.06 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.71 | -63.32% | 🇺🇸 USA |